title: Cholesterol atheroembolism and combined treatment with steroids and iloprost.
abstract: Cholesterol atheroembolism (CAE) is a systemic disorder whose incidence has increased in recent decades and that presents high morbidity and mortality. Although several therapeutic alternatives have been reported, there is no consensus about the best treatment for this disease. In this paper we report the case of a patient with CAE with skin, bowel and kidney involvement who presented a good response to combined therapy with steroids and prostaglandin analogues. Although there are no conclusive studies, we recommend this therapeutic alternative in the management of CAE with organic failure.
authors.affiliation: Servicio de Nefrología. Hospital Universitario 12 de Octubre. Madrid, Spain. sevillano.am@gmail.com
authors.forename: Ángel M
authors.initials: ÁM
authors.lastname: Sevillano-Prieto
authors.forename: Eduardo
authors.initials: E
authors.lastname: Hernández-Martínez
authors.forename: Jara
authors.initials: J
authors.lastname: Caro-Espada
authors.forename: María
authors.initials: M
authors.lastname: Molina-Gómez
authors.forename: Eduardo
authors.initials: E
authors.lastname: Gutiérrez-Martínez
authors.forename: Enrique
authors.initials: E
authors.lastname: Morales-Ruiz
authors.forename: Ester
authors.initials: E
authors.lastname: González-Monte
authors.forename: Manuel
authors.initials: M
authors.lastname: Praga-Terente
mesh_terms: D000368:Aged; D004359:Drug Therapy, Combination; D017700:Embolism, Cholesterol / Q000188:drug therapy*; D005260:Female; D006801:Humans; D016285:Iloprost / Q000627:therapeutic use*; D013256:Steroids / Q000627:therapeutic use*
chemical_list: D013256:Steroids; D016285:Iloprost